Home Cart Sign in  
Chemical Structure| 923288-90-8 Chemical Structure| 923288-90-8

Structure of 923288-90-8

Chemical Structure| 923288-90-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Nilotinib monohydrochloride monohydrate is a second-generation tyrosine kinase inhibitor (TKI), significantly potent against BCR-ABL, and active against many BCR-ABL mutants.

Synonyms: AMN107 monohydrochloride monohydrate; Nilotinib (hydrochloride hydrate); AMN-107 hydrochloride monohydrate

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Nilotinib monohydrochloride monohydrate

CAS No. :923288-90-8
Formula : C28H25ClF3N7O2
M.W : 583.99
SMILES Code : O=C(NC1=CC(C(F)(F)F)=CC(N2C=C(C)N=C2)=C1)C3=CC=C(C)C(NC4=NC=CC(C5=CC=CN=C5)=N4)=C3.[H]Cl.[H]O[H]
Synonyms :
AMN107 monohydrochloride monohydrate; Nilotinib (hydrochloride hydrate); AMN-107 hydrochloride monohydrate
MDL No. :MFCD18251359
InChI Key :YCBPQSYLYYBPDW-UHFFFAOYSA-N
Pubchem ID :16757572

Safety of Nilotinib monohydrochloride monohydrate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Nilotinib monohydrochloride monohydrate

RTK

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01223898 Chronic Myeloid Leukemia PHASE1 COMPLETED 2025-12-13 Novartis Investigative Site, F... More >>rankfurt/M, 60590, Germany|Novartis Investigative Site, Jena, 07740, Germany|Novartis Investigative Site, Mannheim, 68167, Germany|Novartis Investigative Site, Ulm, 89081, Germany|Novartis Investigative Site, Glasgow, G12 0YN, United Kingdom Less <<
NCT01261429 Pigmented Villonodular Synovit... More >>is Less << PHASE2 COMPLETED 2025-04-13 Institut Bergonié, Bordeaux, F... More >>rance|Centre Oscar Lambret, Lille, France|Centre Léon Bérard, Lyon, France|H?pital La Timone, Marseille, France|Institut Paoli Calmettes, Marseille, France|Institut Curie, Paris, France|Institut Claudius Regaud, Toulouse, France|Institut Gustave Roussy, Villejuif, France|Istituto Nazionale dei Tumori, Milano, Italy|Regina Elena National Cancer Institute, Roma, Italy|Leiden University Medical Center, Leiden, Netherlands|Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands|Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland|University College Hospital UCL Hospitals NHS Foundation Trust, London, United Kingdom|Oxford Cancer Centre, Oxford, United Kingdom Less <<
NCT01275586 Neurofibromatosis|NF1|Neurofib... More >>romas Less << EARLY_PHASE1 COMPLETED 2025-10-16 Riley Hospital for Children, I... More >>ndianapolis, Indiana, 46202, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.71mL

0.34mL

0.17mL

8.56mL

1.71mL

0.86mL

17.12mL

3.42mL

1.71mL

References

 

Historical Records

Categories